Part,  Chapter, Paragraph

1   II,     5.  5.  3|         evaluating the efficacy of interventional programs. In MS epidemiological
2   IV,    11.  4    |            effectiveness aspects~· Interventional clinical research, mainly
3   IV,    11.  4    | technologies and reports on single interventional procedures. Transparency